Evidence map›Paper›PMID 42367326›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2026

Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.

Ellen Dobrijevic, Anita van Zwieten, Allison Jaure, Armando Teixeira-Pinto, Sergio A Acuna, Curie Ahn, Eric Au, Christopher Blosser, Jonathan C Craig, Dale Coghlan and 19 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ellen DobrijevicSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Anita van ZwietenSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Allison JaureSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Armando Teixeira-PintoSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Sergio A AcunaDepartment of Surgery, Division of Transplantation, The University of Alabama at Birmingham, Birmingham, AL, United States.
Curie AhnSeoul National University, Gwanak-gu, Republic of Korea.
Eric AuChildren's Hospital at Westmead Centre for Kidney Research, Westmead, NSW, Australia.
Christopher BlosserDepartment of Medicine, University of Washington, Seattle, WA, United States.
Jonathan C CraigCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Dale CoghlanCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Bianca DavidsonDivision of Nephrology and Hypertension, Groote Schuur Hospital, Observatory, South Africa.
Beatriz Dominguez-Gil GonzalezOrganizacion Nacional de Trasplantes, Madrid, Spain.
Anna FrancisDepartment of Nephrology, Queensland Children's Hospital, South Brisbane, QLD, Australia.
Chandana GuhaSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Martin HowellSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Anastasia HughesSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Kenar D JhaveriNorthwell Health, New Hyde Park, NY, United States.
Kenneth A NewellEmory University School of Medicine, Atlanta, GA, United States.
Jolanta MalyszkoDepartment of Nephrology, Dialysis and Internal Medicine, Warszawski Uniwersytet Medyczny, Warsaw, Poland.
Alejandra Mena-GutierrezWake Forest University School of Medicine, Winston-Salem, NC, United States.
Naoka MurakamiDepartment of Medicine, Washington University in St Louis, St. Louis, MO, United States.
Colm O'ReillySchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Javier Recabarren-SilvaSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Dharshana SabanayagamSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Nicole Scholes-RobertsonSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.
Amanda SluiterChildren's Hospital at Westmead Centre for Kidney Research, Westmead, NSW, Australia.
Helio Tedesco Silva JuniorNephrology Division, Universidade Federal de Sao Paulo, São Paulo, Brazil.
Andrea K ViecelliAustralasian Kidney Trials Network, The University of Queensland, QLD, Brisbane, Australia.
Germaine WongSchool of Public Health, The University of Sydney, Darlington, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a critically important outcome for kidney transplant recipients that inconsistently and infrequently reported in trials. We convened a consensus workshop to establish a core outcome measure for cancer for trials in kidney transplant recipients. Workshop attendees included 21 transplant recipients, 2 caregivers and 46 health professionals from 12 countries. Transcripts were analyzed thematically. Three themes were identified. "

Indexed as

Kidney TransplantationNeoplasmsOutcome Assessment, Health CareClinical Trials as TopicHumansImmunosuppressive AgentsKidney Failure, ChronicNephrologyTreatment OutcomeImmunosuppressive Agentscancerchronic kidney diseasecore outcome measurekidney transplantationpatient-centered outcomes

Identifiers

PMID42367326
PMCPMC13294766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.